FDMD.F Stock Overview
Operates as a medical technology company in the United States and Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
4DMedical Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.34 |
| 52 Week High | AU$0.60 |
| 52 Week Low | AU$0.32 |
| Beta | 1.34 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | -27.38% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -79.27% |
Recent News & Updates
Recent updates
Shareholder Returns
| FDMD.F | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 0% | -10.1% | -2.1% |
| 1Y | -27.4% | 5.6% | 29.7% |
Return vs Industry: FDMD.F underperformed the US Healthcare Services industry which returned 6.6% over the past year.
Return vs Market: FDMD.F underperformed the US Market which returned 29.6% over the past year.
Price Volatility
| FDMD.F volatility | |
|---|---|
| FDMD.F Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 8.1% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.6% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: FDMD.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine FDMD.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 145 | Andreas Fouras | 4dmedical.com |
4DMedical Limited operates as a medical technology company in the United States and Australia. It engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. The company also offers X-ray velocimetry lung ventilation analysis software (XV LVAS), a lung airflow imaging software, that provides lung health detail from X-Ray scans; computed tomography lung ventilation analysis software (CT LVAS), an image processing software which operates on CT scans to provide functional lung health detail; XV Scanner, a lung function scanner; and Permetium, a multi-function imaging system for pulmonary investigations.
4DMedical Limited Fundamentals Summary
| FDMD.F fundamental statistics | |
|---|---|
| Market cap | US$128.55m |
| Earnings (TTM) | -US$23.23m |
| Revenue (TTM) | US$2.42m |
53.0x
P/S Ratio-5.5x
P/E RatioIs FDMD.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FDMD.F income statement (TTM) | |
|---|---|
| Revenue | AU$3.75m |
| Cost of Revenue | AU$236.72k |
| Gross Profit | AU$3.52m |
| Other Expenses | AU$39.50m |
| Earnings | -AU$35.98m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.088 |
| Gross Margin | 93.69% |
| Net Profit Margin | -958.34% |
| Debt/Equity Ratio | 0% |
How did FDMD.F perform over the long term?
See historical performance and comparison